期刊
CELL METABOLISM
卷 20, 期 5, 页码 703-705出版社
CELL PRESS
DOI: 10.1016/j.cmet.2014.10.017
关键词
-
资金
- NCI NIH HHS [P01 CA077839] Funding Source: Medline
A substantive literature has accumulated implicating sphingolipids, in particular ceramides, as mediators of insulin resistance in metabolic syndrome. Thanks to recent technical advances in mouse genetics and lipidomics, two independent laboratories identify the same sphingolipid, C16: 0-ceramide, as principal mediator of obesity-related insulin resistance (Turpin et al., 2014; Raichur et al., 2014).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据